These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15658364)

  • 1. [Tacrolimus hydrate (tacrolimus)].
    Matsuda J
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():465-8. PubMed ID: 15658364
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cyclosporine].
    Yuhki Y; Tadano K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():461-4. PubMed ID: 15658363
    [No Abstract]   [Full Text] [Related]  

  • 3. Switching from intravenous to oral tacrolimus and voriconazole leads to a more pronounced drug-drug interaction.
    Spriet I; Grootaert V; Meyfroidt G; Debaveye Y; Willems L
    Eur J Clin Pharmacol; 2013 Mar; 69(3):737-8. PubMed ID: 22878691
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial.
    Pascual J; del Castillo D; Cabello M; Pallardó L; Grinyó JM; Fernández AM; Brunet M
    Transplantation; 2010 Apr; 89(8):994-1000. PubMed ID: 20335831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic drug monitoring of once-daily tacrolimus (Advagraf) in a gastrectomized kidney transplant recipient.
    Ma TK; Chow KM; Kwan BC; Leung CB; Szeto CC; Li PK
    Nephrology (Carlton); 2017 Feb; 22(2):184. PubMed ID: 28064453
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction between FK 506 and diltiazem in an animal model.
    Regazzi MB; Iacona I; Alessiani M; Spada M; Vaccarisi S; Villani P; Molinaro M
    Transplant Proc; 1996 Apr; 28(2):1017-8. PubMed ID: 8623215
    [No Abstract]   [Full Text] [Related]  

  • 7. Understanding and Preventing Adverse Effects of Tacrolimus Metabolization in Transplant Patients.
    Fröhlich E
    Curr Drug Metab; 2019; 20(13):1039-1040. PubMed ID: 30081785
    [No Abstract]   [Full Text] [Related]  

  • 8. Tacrolimus dose individualization in "de novo" patients after 10 years of experience in liver transplantation: pharmacokinetic considerations and patient pathophysiology.
    Valdivieso N; Oteo I; Valdivieso A; Lukas JC; Leal N; Gastaca M; de Urbina JO; Calvo R; Suarez E
    Int J Clin Pharmacol Ther; 2013 Jul; 51(7):606-14. PubMed ID: 23735178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus severe overdosage after intake of masked grapefruit in orange marmalade.
    Peynaud D; Charpiat B; Vial T; Gallavardin M; Ducerf C
    Eur J Clin Pharmacol; 2007 Jul; 63(7):721-2. PubMed ID: 17530235
    [No Abstract]   [Full Text] [Related]  

  • 10. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients.
    Staatz CE; Willis C; Taylor PJ; Tett SE
    Clin Pharmacol Ther; 2002 Dec; 72(6):660-9. PubMed ID: 12496747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
    Shenoy S; Hardinger KL; Crippin J; Korenblat K; Lisker-Melman M; Lowell JA; Chapman W
    Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suggested guidelines for the use of tacrolimus in cardiac transplant recipients.
    Taylor DO; Barr ML; Meiser BM; Pham SM; Mentzer RM; Gass AL
    J Heart Lung Transplant; 2001 Jul; 20(7):734-8. PubMed ID: 11448799
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetic characteristics of two types of liposomal FK 506.
    Yagura K; Nakajima Y; Ko S; Kanehiro H; Nakano H
    Transplant Proc; 1996 Jun; 28(3):1390-1. PubMed ID: 8658708
    [No Abstract]   [Full Text] [Related]  

  • 14. Adequate exposure to tacrolimus with sublingual administration in pediatric liver transplant patients.
    Riva N; Galván ME; Cáceres-Guido P; Dip M; Licciardone N; Imventarza O; Schaiquevich P; Buamscha D
    Int J Clin Pharmacol Ther; 2017 Apr; 55(4):352-354. PubMed ID: 28079516
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction between tacrolimus and omeprazole in a pediatric liver transplant recipient.
    Moreau C; Debray D; Loriot MA; Taburet AM; Furlan V
    Transplantation; 2006 Feb; 81(3):487-8. PubMed ID: 16477241
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tacrolimus hydrate (tacrolimus)].
    Matsuda J
    Nihon Rinsho; 1999 Sep; 57 Suppl():432-5. PubMed ID: 10543146
    [No Abstract]   [Full Text] [Related]  

  • 17. Making every drop count for pediatric kidney transplant patients.
    Clark SL; Taylor A; Shaw KN; Copelovitch L
    Hosp Pediatr; 2015 May; 5(5):287-9. PubMed ID: 25934814
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood concentrations and side effects of tacrolimus in a living renal transplantation].
    Ishikawa M; Abo K; Nanba A; Satoh S; Mikawa Y; Higashi T; Nakamura K; Miyazaki M
    Masui; 2001 Mar; 50(3):246-50. PubMed ID: 11296433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bronchodilator: theophylline].
    Nishihara K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():414-8. PubMed ID: 15658352
    [No Abstract]   [Full Text] [Related]  

  • 20. Once daily tacrolimus formulation: monitoring of plasma levels, graft function, and cardiovascular risk factors.
    Meçule A; Poli L; Nofroni I; Bachetoni A; Tinti F; Umbro I; Barile M; Berloco PB; Mitterhofer AP
    Transplant Proc; 2010 May; 42(4):1317-9. PubMed ID: 20534290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.